How to buy Proteomics International Laboratories shares | A$0.55

Proteomics International Laboratories Limited is a biotechnology business based in Australia. Proteomics International Laboratories shares (PIQ) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $0.55 – a decrease of 2.65% over the previous week. Proteomics International Laboratories has a trailing 12-month revenue of around $2.7 million.

How to buy shares in Proteomics International Laboratories

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Proteomics International Laboratories . Find the share by name or ticker symbol: PIQ. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Proteomics International Laboratories reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $0.55, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Proteomics International Laboratories . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

🧪How we chose these brokers

For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.

How has coronavirus impacted Proteomics International Laboratories 's share price?

Since the stock market crash in March caused by coronavirus, Proteomics International Laboratories 's share price has had significant positive movement.

Its last market close was $0.55, which is 41.82% up on its pre-crash value of $0.32 and 182.05% up on the lowest point reached during the March crash when the shares fell as low as $0.195.

If you had bought $1,000 worth of Proteomics International Laboratories shares at the start of February 2020, those shares would have been worth $769.23 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,115.38.

Proteomics International Laboratories share price

Use our graph to track the performance of PIQ stocks over time.

Proteomics International Laboratories shares at a glance

• Key figures

Information last updated 2020-10-20.

Latest market close	AUDA$0.55
52-week range	AUDA$0.195 - AUDA$0.695
50-day moving average	AUDA$0.5451
200-day moving average	AUDA$0.4633
Target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	AUDA$-0.026

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Proteomics International Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Proteomics International Laboratories Limited by TradingView

Proteomics International Laboratories price performance over time

Historical closes compared with the close of A$0.55 on 2020-10-22

1 week (2020-10-16)	-2.65%
1 month (2020-09-24)	13.40%
3 months (2020-07-24)	5.77%
6 months (2020-04-24)	77.42%

1 year (2019-10-24)	61.76%
2 years (2018-10-24)	103.70%
3 years (2017-10-23)	197.30%
5 years (2015-10-23)	71.88%

Proteomics International Laboratories financials

Revenue TTM	$2.7 million
Gross profit TTM	$1.9 million
Return on assets TTM	-27.36%
Return on equity TTM	-46.98%
Profit margin	-63.9%
Book value	0.048
Market capitalisation	$50.8 million

TTM: trailing 12 months

Proteomics International Laboratories share dividends

We're not expecting Proteomics International Laboratories to pay a dividend over the next 12 months.

Proteomics International Laboratories share price volatility

Over the last 12 months, Proteomics International Laboratories 's shares have ranged in value from as little as $0.195 up to $0.695. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Proteomics International Laboratories 's is 1.4144. This would suggest that Proteomics International Laboratories 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Proteomics International Laboratories overview

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research, analytical, and consultancy. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute to enhance diagnosis and treatment of lung conditions, such as asthma and chronic obstructive pulmonary disease; the Janssen Research & Development, LLC for the research of diabetic kidney and heart disease treatment; and partnership with QIMR Berghofer Medical Research Institute for the detection of oesophageal adenocarcinoma, the primary common form of oesophageal cancer in Australia. The company was founded in 2001 and is based in Perth, Australia.

Frequently asked questions

• What percentage of Proteomics International Laboratories is owned by insiders?

  Currently 47.549% of Proteomics International Laboratories shares are held by insiders.

• When does the fiscal year end for Proteomics International Laboratories ?

  Proteomics International Laboratories 's fiscal year ends in June.

• Where is Proteomics International Laboratories based?

  Proteomics International Laboratories 's address is: QEII Medical Centre, Perth, WA, Australia, 6009

• What is Proteomics International Laboratories 's ISIN number?

  Proteomics International Laboratories 's international securities identification number is: AU000000PIQ0